Literature DB >> 3493723

Maternal and fetal outcome in neonatal lupus erythematosus.

A B McCune, W L Weston, L A Lee.   

Abstract

Maternal health, children's health, and obstetric histories were assessed in a follow-up study of 21 families with children with neonatal lupus erythematosus; this group constituted approximately 15% of all reported cases. Twenty-one mothers had twenty-four children with the disease. Twelve children had congenital heart block (5 boys, 7 girls), 10 had cutaneous lupus lesions (1 boy, 9 girls), and 2 girls had both heart block and cutaneous lesions. Although half of the mothers were initially asymptomatic, 18 of 21 have developed symptoms during the follow-up period (range, 0.25 to 9.5 years). Three of the children died in the neonatal period. The 21 children who survived have been asymptomatic during follow-up, although 5 of 11 with heart block have pacemakers. The mothers did not have an increased risk for spontaneous abortions. Three of twelve livebirths after the birth of the first child with neonatal lupus erythematosus resulted in another affected child.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493723     DOI: 10.7326/0003-4819-106-4-518

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  21 in total

Review 1.  Anti-Ro antibodies and neonatal lupus.

Authors:  P J Maddison
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 2.  [Chronic inflammatory and autoimmune mediated dermatoses during pregnancy. Course and prognosis for mother and child].

Authors:  R Renner; M Sticherling
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

Review 3.  Antinuclear antibodies to RNA-binding proteins in SLE.

Authors:  P J Maddison
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

4.  Renal involvement in primary Sjogren's syndrome: a prospective cohort study.

Authors:  Ankit Jain; Bheemanathi Hanuman Srinivas; Dantis Emmanuel; Vikramraj K Jain; Sreejith Parameshwaran; Vir Singh Negi
Journal:  Rheumatol Int       Date:  2018-08-23       Impact factor: 2.631

5.  Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.

Authors:  B T Kurien; A Dsouza; A Igoe; Y J Lee; J S Maier-Moore; T Gordon; M Jackson; R H Scofield
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

6.  A case of neonatal lupus erythematosus showing transient anemia and hepatitis.

Authors:  Kyu Ri Kim; Tae Young Yoon
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

7.  Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset.

Authors:  A Siamopoulou-Mavridou; M N Manoussakis; A K Mavridis; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

8.  Prognostic value of Sjögren's syndrome autoantibodies.

Authors:  R Hal Scofield; Anum Fayyaz; Biji T Kurien; Kristi A Koelsch
Journal:  J Lab Precis Med       Date:  2018-10-30

9.  Stimulation of anti-RNP antibody binding to cultured keratinocytes by estradiol.

Authors:  F Furukawa; S Imamura; D A Norris
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

10.  Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus.

Authors:  T L Rivera; P M Izmirly; B K Birnbaum; P Byrne; J B Brauth; M Katholi; M Y Kim; J Fischer; R M Clancy; J P Buyon
Journal:  Ann Rheum Dis       Date:  2008-07-14       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.